Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross-Sectional Study in Beirut, Lebanon

Farah Naja, Bilal Anouti, Hibeh Shatila, Reem Akel, Yolla Haibe, Arafat Tfayli, Farah Naja, Bilal Anouti, Hibeh Shatila, Reem Akel, Yolla Haibe, Arafat Tfayli

Abstract

Patients with lung cancer are increasingly seeking complementary and alternative medicine (CAM) to improve their physiological and psychological well-being. This study aimed to assess CAM use among lung cancer patients in Lebanon. Using a cross-sectional design, 150 lung cancer patients attending the Basile Cancer Institute at the American University of Beirut Medical Center were interviewed. Participants completed a questionnaire addressing sociodemographic characteristics, lung cancer condition, and use of CAM. The main outcome of interest was "use of any CAM therapy since diagnosis." Prevalence of CAM use was 41%. The most commonly used CAM modality among study participants was "dietary supplements/special foods." Results of the multiple logistic regression analyses showed that CAM use was positively associated with Lebanese nationality and paying for treatment out of pocket and was negatively associated with unemployment and having other chronic diseases. About 10% of patients used CAM on an alternative base, 58% did not disclose CAM use to their physician, and only 2% cited health professionals as influencing their choice of CAM. This study revealed a prevalent CAM use among lung cancer patients in Lebanon, with a marginal role for physicians in guiding this use. Promoting an open-communication and a patient-centered approach regarding CAM use is warranted.

Figures

Figure 1
Figure 1
Types of CAM used in the study population (n = 62).

References

    1. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. 2010;127(12):2893–2917. doi: 10.1002/ijc.25516.
    1. WHO. GlOBOCAN 2012: Estimated Cancer Incidence, Mortality abd Prevalence Worldwide in 2012," .
    1. Salim E. I., Jazieh A. R., Moore M. A. Lung cancer incidence in the Arab league countries: risk factors and control. Asian Pacific Journal of Cancer Prevention. 2011;12(1):17–34.
    1. El Saghir N. S. An update on recent cancer trends in Lebanon. Ethnicity and Disease. 2005:11–17.
    1. Shamseddine A. I., Musallam K. M. Cancer epidemiology in Lebanon. Middle East Journal of Cancer. 2010;1(1):41–44.
    1. Shamseddine A., Saleh A., Charafeddine M., et al. Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Population Health Metrics. 2014;12(1, article no. 4) doi: 10.1186/1478-7954-12-4.
    1. WHO. "Fact sheet : Cancer," 2017,
    1. Novello S., Barlesi F., Califano R., et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2016;27:V1–V27. doi: 10.1093/annonc/mdw326.
    1. C. C. Society, "Lung Cancer Statistics," 2016, .
    1. C. R. UK, "Lung Cancer Statistics," 2016, .
    1. Potter J., Higginson I. J. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology. Lung Cancer. 2004;43(3):247–257. doi: 10.1016/j.lungcan.2003.08.030.
    1. Carlsen K., Jensen A. B., Jacobsen E., Krasnik M., Johansen C. Psychosocial aspects of lung cancer. Lung Cancer. 2005;47(3):293–300. doi: 10.1016/j.lungcan.2004.08.002.
    1. Fox P., Butler M., Coughlan B., et al. Using a mixed methods research design to investigate complementary alternative medicine (CAM) use among women with breast cancer in Ireland. European Journal of Oncology Nursing. 2013;17(4):490–497. doi: 10.1016/j.ejon.2012.10.008.
    1. Chen Z., Gu K., Zheng Y., Zheng W., Lu W., Shu X. O. The use of complementary and alternative medicine among Chinese women with breast cancer. The Journal of Alternative and Complementary Medicine. 2008;14(8):1049–1055. doi: 10.1089/acm.2008.0039.
    1. Molassiotis A., Fernandez-Ortega P., Pud D., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Annals of Oncology. 2005;16(4):655–663. doi: 10.1093/annonc/mdi110.
    1. National Center for Complimentary and Integrative Health. The Use of Complementary and Alternative Medicine in the United States. 2016, .
    1. Edirne T., Arica S. G., Gucuk S., et al. Use of complementary and alternative medicines by a sample of Turkish women for infertility enhancement: a descriptive study. BMC Complementary and Alternative Medicine. 2010;10, article 11 doi: 10.1186/1472-6882-10-11.
    1. Moadel A. B., Shah C., Wylie-Rosett J., et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. Journal of Clinical Oncology. 2007;25(28):4387–4395. doi: 10.1200/jco.2006.06.6027.
    1. National Center for Complementary and Integrative Health. Cancer: In Depth. 2016, .
    1. Yates J. S., Mustian K. M., Morrow G. R., et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Supportive Care in Cancer. 2005;13(10):806–811. doi: 10.1007/s00520-004-0770-7.
    1. Richardson M. A., Sanders T., Palmer J. L., Greisinger A., Singletary S. E. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology. 2000;18(13):2505–2514. doi: 10.1200/JCO.2000.18.13.2505.
    1. Rausch S. M., Winegardner F., Kruk K. M., et al. Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Supportive Care in Cancer. 2011;19(4):521–529. doi: 10.1007/s00520-010-0846-5.
    1. Fouladbakhsh J. M., Stommel M., Given B. A., Given C. W. Predictors of use of complementary and alternative therapies among patients with cancer. Oncology Nursing Forum. 2005;32(6):1115–1122. doi: 10.1188/05.ONF.1115-1122.
    1. Ali-Shtayeh M. S., Jamous R. M., Salameh N. M. Y., Jamous R. M., Hamadeh A. M. A. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns. Journal of Ethnopharmacology. 2016;187:104–122. doi: 10.1016/j.jep.2016.04.038.
    1. Pirri C., Katris P., Trotter J., Bayliss E., Bennett R., Drummond P. Use of complementary and alternative therapies by Western Australian cancer patients. Asia-Pacific Journal of Clinical Oncology. 2008;4(3):161–169. doi: 10.1111/j.1743-7563.2008.00180.x.
    1. Oh B., Butow P., Mullan B., et al. The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pacific Journal of Clinical Oncology. 2010;6(4):342–349. doi: 10.1111/j.1743-7563.2010.01329.x.
    1. Afifi F. U., Wazaify M., Jabr M., Treish E. The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan. Complementary Therapies in Clinical Practice. 2010;16(4):208–212. doi: 10.1016/j.ctcp.2010.05.001.
    1. Molassiotis A., Panteli V., Patiraki E., et al. Complementary and alternative medicine use in lung cancer patients in eight European countries. Complementary Therapies in Clinical Practice. 2006;12(1):34–39. doi: 10.1016/j.ctcp.2005.09.007.
    1. Micke O., Büntzel J., Kisters K., Schäfer U., Micke P., Mücke R. Complementary and alternative medicine in lung cancer patients: a neglected phenomenon? Frontiers of Radiation Therapy and Oncology. 2010;42:198–205. doi: 10.1159/000262477.
    1. Klafke N., Eliott J. A., Wittert G. A., Olver I. N. Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Annals of Oncology. 2012;23(6):1571–1578. doi: 10.1093/annonc/mdr521.
    1. Furnham A., Smith C. Choosing alternative medicine: a comparison of the beliefs of patients visiting a general practitioner and a homoeopath. Social Science and Medicine. 1988;26(7):685–689. doi: 10.1016/0277-9536(88)90060-3.
    1. Thorne S., Paterson B., Russell C., Schultz A. Complementary/alternative medicine in chronic illness as informed self-care decision making. International Journal of Nursing Studies. 2002;39(7):671–683. doi: 10.1016/S0020-7489(02)00005-6.
    1. Cassileth B. R., Deng G. E., Gomez J. E., Johnstone P. A. S., Kumar N., Vickers A. J. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines. CHEST Journal. 2007;132(3):340S–354S. doi: 10.1378/chest.07-1389.
    1. Klein J., Griffiths P. Acupressure for nausea and vomiting in cancer patients receiving chemotherapy. British Journal of Community Nursing. 2004;9(9):383–387. doi: 10.12968/bjcn.2004.9.9.15936.
    1. Bao T. Use of acupuncture in the control of chemotherapy-induced nausea and vomiting. Journal of the National Comprehensive Cancer Network. 2009;7(5):606–612. doi: 10.6004/jnccn.2009.0041.
    1. Pan C. X., Morrison R. S., Ness J., Fugh-Berman A., Leipzig R. M. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of Life: a systematic review. Journal of Pain and Symptom Management. 2000;20(5):374–387. doi: 10.1016/S0885-3924(00)00190-1.
    1. Bardia A., Barton D. L., Prokop L. J., Bauer B. A., Moynihan T. J. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. Journal of Clinical Oncology. 2006;24(34):5457–5464. doi: 10.1200/jco.2006.08.3725.
    1. Conn V. S., Hafdahl A. R., Porock D. C., McDaniel R., Nielsen P. J. A meta-analysis of exercise interventions among people treated for cancer. Supportive Care in Cancer. 2006;14(7):699–712. doi: 10.1007/s00520-005-0905-5.
    1. Yarney J., Donkor A., Opoku S. Y., et al. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study. BMC Complementary & Alternative Medicine. 2013;13, article 16 doi: 10.1186/1472-6882-13-16.
    1. GVR. Alternative and complementary medicine market analysis by intervention (botanicals, acupuncture, mind, body, and yoga, magnetic intervention), by distribution method, and segment forecasts, 2013 - 2025. 2017
    1. Alameddine M., Naja F., Abdel-Salam S., Maalouf S., Matta C. Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study. BMC Complementary and Alternative Medicine. 2011;11, article 71 doi: 10.1186/1472-6882-11-71.
    1. Wells M., Sarna L., Cooley M. E., et al. Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nursing. 2007;30(1):45–55. doi: 10.1097/00002820-200701000-00008.
    1. Bauml J., Langer C. J., Evans T., Garland S. N., Desai K., Mao J. J. Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey. Supportive Care in Cancer. 2014;22(9):2465–2472. doi: 10.1007/s00520-014-2220-5.
    1. Chang H.-Y., Wallis M., Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. Journal of Advanced Nursing. 2007;58(4):307–319. doi: 10.1111/j.1365-2648.2007.04291.x.
    1. Naja F., Fadel R. A., Alameddine M., et al. Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study. BMC Complementary and Alternative Medicine. 2015;15, article 444 doi: 10.1186/s12906-015-0969-9.
    1. Naja F., Alameddine M., Itani L., Shoaib H., Hariri D., Talhouk S. The use of complementary and alternative medicine among lebanese adults: results from a national survey. Evidence-based Complementary and Alternative Medicine. 2015;2015:9. doi: 10.1155/2015/682397.682397
    1. Ching S. M., Zakaria Z. A., Paimin F., Jalalian M. Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complementary and Alternative Medicine. 2013;13, article 148 doi: 10.1186/1472-6882-13-148.
    1. Hasan S. S., Ahmed S. I., Bukhari N. I., Loon W. C. W. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complementary Therapies in Clinical Practice. 2009;15(3):152–157. doi: 10.1016/j.ctcp.2009.02.003.
    1. Wanchai A., Armer J. M., Stewart B. R. Complementary and alternative medicine use among women with breast cancer: a systematic review. Clinical Journal of Oncology Nursing. 2010;14(4):E45–E55. doi: 10.1188/10.cjon.e45-e55.
    1. THE WORLD BANK. World Bank national accounts data, and OECD National Accounts data files. 2017, .
    1. Saad B., Azaizeh H., Abu-Hijleh G., Said O. Safety of traditional Arab herbal medicine. Evidence-Based Complementary and Alternative Medicine. 2006;3(4):433–439. doi: 10.1093/ecam/nel058.
    1. Salah S. M., Jäger A. K. Screening of traditionally used Lebanese herbs for neurological activities. Journal of Ethnopharmacology. 2005;97(1):145–149. doi: 10.1016/j.jep.2004.10.023.
    1. Slifman N. R., Obermeyer W. R., Aloi B. K., et al. Contamination of botanical dietary supplements by Digitalis lanata. New England Journal of Medicine. 1998;339(12):806–811. doi: 10.1056/NEJM199809173391204.
    1. Cheng B., Hung C. T., Chiu W. Herbal medicine and anaesthesia. Hong Kong Medical Journal. 2002;8(2):123–130.
    1. Malik I. A., Gopalan S. Use of CAM results in delay in seeking medical advice for breast cancer. European Journal of Epidemiology. 2003;18(8):817–822. doi: 10.1023/A:1025343720564.
    1. Sobel R. Science and nescience: the issue of alternative medicine. Public Health Reviews. 1999;27(4):247–260.
    1. Hufford D. J. Evaluating complementary and alternative medicine: the limits of science and of scientists. Journal of Law, Medicine and Ethics. 2003;31(2):198–212. doi: 10.1111/j.1748-720x.2003.tb00081.x.
    1. Morreim E. H. A dose of our own medicine: alternative medicine, conventional medicine, and the standards of science. Journal of Law, Medicine and Ethics. 2003;31(2):222–235. doi: 10.1111/j.1748-720x.2003.tb00083.x.
    1. Pagán J. A., Puig A. Differences in access to health care services between insured and uninsured adults with diabetes in Mexico. Diabetes Care. 2005;28(2):425–426. doi: 10.2337/diacare.28.2.425.
    1. Kaptchuk T. J. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Annals of Internal Medicine. 2002;136(11):817–825. doi: 10.7326/0003-4819-136-11-200206040-00011.
    1. Verhoef M. J. Declining conventional cancer treatment and using Complementary and Alternative Medicine: a problem or a challenge? Current Oncology. 2008;15(0) doi: 10.3747/co.v15i0.281.
    1. Abou-Rizk J., Alameddine M., Naja F. Prevalence and characteristics of cam use among people living with hiv and aids in lebanon: implications for patient care. Evidence-Based Complementary and Alternative Medicine. 2016;2016:1–11. doi: 10.1155/2016/5013132.
    1. Naja F., Alameddine M., Abboud M., Bustami D., Al Halaby R. Complementary and alternative medicine use among pediatric patients with leukemia: the case of Lebanon. Integrative Cancer Therapies. 2011;10(1):38–46. doi: 10.1177/1534735410384591.
    1. Davis E. L., Oh B., Butow P. N., Mullan B. A., Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist. 2012;17(11):1475–1481. doi: 10.1634/theoncologist.2012-0223.
    1. Wright K. B., Sparks L., O'hair H. D. Health communication in the 21st century. John Wiley Sons; 2012.
    1. Ge J., Fishman J., Vapiwala N. Patient-physician communication about complementary and alternative medicine in a radiation oncology setting. International Journal of Radiation Oncology, Biology, Physics. 2013;85(1):e1–e6. doi: 10.1016/j.ijrobp.2012.08.018.
    1. Bjerså K., Stener Victorin E., Fagevik Olsén M. Knowledge about complementary, alternative and integrative medicine (CAM) among registered health care providers in Swedish surgical care: a national survey among university hospitals. BMC Complementary and Alternative Medicine. 2012;12, article no. 42 doi: 10.1186/1472-6882-12-42.
    1. Winslow L. C., Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Archives of Internal Medicine. 2002;162(10):1176–1181. doi: 10.1001/archinte.162.10.1176.
    1. Bowling A. Mode of questionnaire administration can have serious effects on data quality. Journal of Public Health. 2005;27(3):281–291. doi: 10.1093/pubmed/fdi031.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren